The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet ...

BOSTON and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company ...

Greetings and welcome to the PDS Biotech first quarter in 2025 earnings conference call. (operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The Barbara Ann Karmanos Cancer Institute's Office of Community Outreach and Engagement (COE) is partnering with the Detroit ...

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) were trading at $30.25, down $5.60, or 15%, on word of the delay of data from the phase III X-tole2 trial with azetukalner in focal onset seizures ...

A new clinic, opened by a pulmonologist who lost his home in the Palisades blaze, is addressing the health issues developing ...

Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...

Get any of our free email newsletters — news headlines, e-edition, prep sports, obituaries, entertainment and more.